Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020205880 - NEBULIZER FOR TIME-REGULATED DELIVERY

Publication Number WO/2020/205880
Publication Date 08.10.2020
International Application No. PCT/US2020/025992
International Filing Date 31.03.2020
IPC
A61M 11/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
11Sprayers or atomisers specially adapted for therapeutic purposes
CPC
A61M 11/005
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
11Sprayers or atomisers specially adapted for therapeutic purposes
005using ultrasonics
A61M 15/0021
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
15Inhalators
0001Details of inhalators; Constructional features thereof
0021Mouthpieces therefor
A61M 15/0085
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
15Inhalators
0085using ultrasonics
A61M 2205/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
2205General characteristics of the apparatus
18with alarm
A61M 2205/3592
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
2205General characteristics of the apparatus
35Communication
3576with non implanted data transmission devices, e.g. using external transmitter or receiver
3592using telemetric means, e.g. radio or optical transmission
A61M 2205/52
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY
2205General characteristics of the apparatus
50with microprocessors or computers
52with memories providing a history of measured variating parameters of apparatus or patient
Applicants
  • BN INTELLECTUAL PROPERTIES, INC. [US]/[US]
Inventors
  • PELL, Don
  • HOYT, Mark
  • BOLTON, Matthew
Agents
  • NORANBROCK, Randy A.
Priority Data
62/827,60401.04.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) NEBULIZER FOR TIME-REGULATED DELIVERY
(FR) NÉBULISEUR POUR UNE DISTRIBUTION RÉGULÉE DANS LE TEMPS
Abstract
(EN)
A nebulizer with an active mesh configured to produce a plume of particles for treating medical conditions is activated by a dosage request by a user, produces a plume of particles, at least 95% of which have a diameter between about 0.5 and up to about 5 µm, and tracks delivery of a pharmacological compound in the plume of particles of nebulized solution. The active mesh is configured to turn on, and turn off, during a single inhalation, and to provide a dose of pharmacological compound over at least one inhalation of at least one plume. The active mesh does not produce a plume of particles when no inhalation occurs, to prevent waste and to ensure accurate dosing of pharmacological compound. The nebulizer blocks use of the active mesh when a dosage limit is met, and enables use of the active mesh when a dosing delay time has passed.
(FR)
L'invention concerne un nébuliseur pourvu d'un maillage actif configuré pour produire un panache de particules afin de traiter des troubles médicaux, qui est activé par une demande de dosage d'un utilisateur, produit un panache de particules, dont au moins 95 % ont un diamètre compris entre environ 0,5 et environ 5 µm, et effectue un suivi de la distribution d'un composé pharmacologique dans le panache de particules de solution nébulisée. Le maillage actif est configuré pour s'allumer et s'éteindre, pendant une seule inhalation, et pour fournir une dose de composé pharmacologique sur au moins une inhalation d'au moins un panache. Le maillage actif ne produit pas de panache de particules en l'absence d'inhalation, pour éviter les déchets et assurer un dosage précis du composé pharmacologique. Le nébuliseur bloque l'utilisation du maillage actif lorsqu'un seuil de dosage est atteint, et permet l'utilisation du maillage actif lorsqu'un temps de retard de dosage s'est écoulé.
Latest bibliographic data on file with the International Bureau